Safety, Tolerability and Pharmacokinetics of a Subcutaneous Semaglutide Implant

Summary

The study will evaluate the safety, tolerability and drug levels of a semaglutide implant placed just under the skin for a period of 4 weeks compared to 4 weekly injections of semaglutide (Wegovy) in overweight/obese participants who are otherwise healthy..

Timeline

Start

2026-07

Primary completion

2026-12

Completion

2027-01

Drugs

Indications